• Oluwakemi Alonge MPH, CPH

  • Epidemiologist


    • MCRI - MCRI-Clin Epidem and Pop Hlth
    • 1000 North Oak Ave. ML2 Marshfield, WI 54449

Education

2018 to 2020:
MPH, Epidemiology, Texas A&M University, School of Public Health, College Station, Texas
2012 to 2016:
BSc., Microbiology, Obafemi Awolowo University, Ile-Ife, Nigeria

Work Experience

2021 to Present:
Epidemiologist, Marshfield Clinic Research Institute, Marshfield, WI
2020 to 2021:
Epidemiologist II, Texas Department of State Health Services, Austin, TX
2019 to 2019:
Public Health Graduate Intern, Texas Department of State Health Services, San Antonio, TX
2016 to 2017:
Adverse Drug Reaction (ADR) Surveillance Graduate Intern, National Agency for Food and Drug Administration and Control (NAFDAC), Abuja, Nigeria
2015 to 2015:
Medical Laboratory Assistant, Nigerian National Petroleum Corporation (NNPC) Medical Services, Portharcourt, Nigeria

Statement

Oluwakemi (Kemi) is an epidemiologist and project manager on several epidemiologic studies within the research program. She provides data management and analytic support to study investigators, coordination of research teams, study planning and implementation, protocol development, scientific presentations, manuscript preparation and publication.

After receiving her MPH from Texas A&M University in 2020, Ms. Alonge worked as an epidemiologist for the Texas Department of State Health Services. She served as a subject matter expert on tuberculosis contact investigation and was responsible for managing and analyzing data in the Texas tb contact investigation database. She also performed quality assurance of contact investigation data being reported into the state’s tuberculosis surveillance system.


Research Interests

Infectious diseases; vaccine effectiveness, safety and promotion; disease surveillance; lung cancer and prevention.

Select Publications

  • Olusanya OA, Tomar A, Thomas J, Alonge K, Wigfall LT. Application of the theoretical domains framework to identify factors influencing catch-up HPV vaccinations among male college students in the United States: A review of evidence and recommendations. VACCINE. 2023 May 26;41(23):3564-3576. doi: 10.1016/j.vaccine.2023.04.071.
    PubMed ID: 37164820
  • Alonge, O, Hanson K, Eggebrecht M, Funk P, Christianson B, Williams C,...McLean H [including Belongia E.] COVID-19 Booster Dose Reminder/Recall for Adolescents: Findings From a Health-Care System in Wisconsin. Journal of Adolescent Health. 2023 November 21; 73(5):953-956. doi: 10.1016/j.jadohealth.2023.06.026.
    PubMed ID: 37610391
  • Alonge, OD, Marin, M, Hickman, CJ, Sowers, SB, Chen, M, Hao, L,...Nguyen, Huong. Long-term Neutralizing Antibody Levels Against Measles and Rubella Viruses among Adults with Three Doses of Measles-Mumps-Rubella Vaccine. [published online ahead of print 2024 January 3]. Open Forum Infectious Diseases. 11(1). doi: https://doi.org/10.1093/ofid/ofad700. PMCID: PMC10783245.
    PubMed ID: 38213634
  • Alonge OD, Marin M, Hickman CJ, Sowers SB, Chen MH, Hao L,...Nguyen HQ [including McClure DL.] Long-term Neutralizing Antibody Levels Against Measles and Rubella Viruses Among Adults With 3 Doses of Measles-Mumps-Rubella Vaccine. Open Forum Infect Dis.. 2024 January;11(1):ofad700. doi: 10.1093/ofid/ofad700. PMCID: PMC10783245.
    PubMed ID: 38213634